tirzepatide for kidney disease reduces albuminuria among adults with type 2 diabetes in SURPASS trials Tirzepatide benefits people with obesity,

Join 1000s Who Trust DermOnDemand Effective Customized prescription treatments for rashes within 24 hours Prescriptions sent to your pharmacy (*often covered by insurance) Convenient fast treatments 100% online Rash Treatments About Rashes and Ways to Treat Them Rashes can result from allergic reactions, irritants like soaps or chemicals, infections, or conditions like eczema or psoriasis

Were here to help you stay on track with support that fits your schedule, including same-day appointments

'King Kong' slimming jab Mounjaro approved for weight loss in the UK The obese and overweight who have weight-related condition should get the jab However, it will only be rolled out on the NHS if it receives a further approval See more Daily Mail on Google - save us as a Preferred Source A diabetes drug has been authorised to help obese and overweight adults lose weight, according to the UK's medicines watchdog

Cagrilintide vs AOD 9604 Mechanism: Cagrilintide: Amylin receptor agonist (appetite/satiety) AOD 9604: HGH fragment (fat metabolism) Completely different Weight loss: Cagrilintide: 10-12% body weight AOD 9604: 5-8% body weight (less robust data) Cagrilintide superior Clinical evidence: Cagrilintide: Extensive Phase 2/3 trials AOD 9604: Limited clinical data Cagrilintide better studied Side effects: Cagrilintide: GI effects common AOD 9604: Minimal side effects AOD 9604 better tolerated Combination potential: Could theoretically combine (different mechanisms) No clinical data on combination Cagrilintide + semaglutide better established Verdict: Cagrilintide more powerful, better evidence

Drinking at least 810 glasses of water daily, with additional fluid during and immediately after workouts, maintains electrolyte balance and reduces gastrointestinal upset

reduced appetite, food cravings, food preferences, sensitivity to foods in the environment, and disinhibition, without an effect on dietary restraint compared with placebo in people with obesity